Head-to-head · Value Score
Ondra Health vs Invigor Medical
Two GLP-1 deals, scored on the same six factors. Ondra Health lands a Value Score of 92, Invigor Medical a 82. Here's who gives you the honest lower price — and where each one bites back.
Ondra Health
#2 · Grade A+ · Best Value
Est. first month
$93/mo
Save ~93% vs brand-nameInvigor Medical
#19 · Grade B+ · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
Ondra Health takes it on Value Score, 92 to 82 — an est. $93/mo first month, with no teaser step-up baked in. Invigor Medical isn't out of it: People who want GLP-1 pricing they can see up front alongside a wider wellness/hormone catalog.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Ondra Health | Invigor Medical |
|---|---|---|
| Value Score | 92 (A+) | 82 (B+) |
| Est. first month | $93/mo | $199/mo |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $93/mo | $199/mo |
| Tirzepatide | $166/mo | $339/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Not disclosed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Ondra Health
The cheapest flat semaglutide sticker we track ($93) — LegitScript-certified, all 50 states, and it still offers brand-name access.
Why it's a deal
- Lowest disclosed flat semaglutide price in the roster ($93/mo) — no teaser step-up
- LegitScript-certified and available in all 50 states
- Offers FDA-approved brand-name access alongside compounded
- Tirzepatide is competitive too at $166/mo
The fine print
- Newer name with a shorter public track record than the established flat-fee brands
- No oral/sublingual route for the needle-averse
Invigor Medical
Mid-market flat pricing on both molecules from a long-running, broad-catalog operator.
Why it's a deal
- Both molecules priced up front
- Long-running operator with a broad catalog
- No known teaser-rate tier
The fine print
- Tirzepatide ($339) runs pricier than the best deals
- Does not publish an explicit states-served list
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.